nodes	percent_of_prediction	percent_of_DWPC	metapath
Auranofin—PRDX5—embryo—testicular cancer	0.0504	0.163	CbGeAlD
Auranofin—PRDX5—seminal vesicle—testicular cancer	0.0473	0.153	CbGeAlD
Auranofin—PRDX5—gonad—testicular cancer	0.0342	0.111	CbGeAlD
Auranofin—IKBKB—embryo—testicular cancer	0.0298	0.0967	CbGeAlD
Auranofin—PRDX5—female gonad—testicular cancer	0.0278	0.09	CbGeAlD
Auranofin—PRDX5—testis—testicular cancer	0.0246	0.0799	CbGeAlD
Auranofin—IKBKB—gonad—testicular cancer	0.0202	0.0656	CbGeAlD
Auranofin—PRDX5—lymph node—testicular cancer	0.0179	0.0579	CbGeAlD
Auranofin—IKBKB—female gonad—testicular cancer	0.0165	0.0533	CbGeAlD
Auranofin—IKBKB—testis—testicular cancer	0.0146	0.0473	CbGeAlD
Auranofin—IKBKB—lymph node—testicular cancer	0.0106	0.0343	CbGeAlD
Auranofin—ALB—testis—testicular cancer	0.00852	0.0276	CbGeAlD
Auranofin—IKBKB—Validated transcriptional targets of TAp63 isoforms—TFAP2C—testicular cancer	0.00805	0.131	CbGpPWpGaD
Auranofin—ALB—lymph node—testicular cancer	0.00617	0.02	CbGeAlD
Auranofin—Interstitial pneumonia—Methotrexate—testicular cancer	0.00595	0.00944	CcSEcCtD
Auranofin—IKBKB—FCERI mediated NF-kB activation—BCL10—testicular cancer	0.00589	0.0962	CbGpPWpGaD
Auranofin—IKBKB—Canonical NF-kappaB pathway—BCL10—testicular cancer	0.00589	0.0962	CbGpPWpGaD
Auranofin—Pancytopenia—Chlorambucil—testicular cancer	0.00548	0.00869	CcSEcCtD
Auranofin—Neutropenia—Chlorambucil—testicular cancer	0.00539	0.00856	CcSEcCtD
Auranofin—Neuropathy peripheral—Chlorambucil—testicular cancer	0.00504	0.008	CcSEcCtD
Auranofin—Pancytopenia—Vinblastine—testicular cancer	0.00502	0.00796	CcSEcCtD
Auranofin—Stomatitis—Chlorambucil—testicular cancer	0.00501	0.00795	CcSEcCtD
Auranofin—Jaundice—Chlorambucil—testicular cancer	0.00501	0.00795	CcSEcCtD
Auranofin—Neuropathy peripheral—Vinblastine—testicular cancer	0.00462	0.00733	CcSEcCtD
Auranofin—Gastrointestinal haemorrhage—Ifosfamide—testicular cancer	0.00441	0.007	CcSEcCtD
Auranofin—Agranulocytosis—Vinblastine—testicular cancer	0.0044	0.00698	CcSEcCtD
Auranofin—PRDX5—Cellular responses to stress—H2AFZ—testicular cancer	0.0043	0.0702	CbGpPWpGaD
Auranofin—Pancytopenia—Bleomycin—testicular cancer	0.00424	0.00673	CcSEcCtD
Auranofin—Dysphagia—Dactinomycin—testicular cancer	0.00416	0.0066	CcSEcCtD
Auranofin—Alopecia—Chlorambucil—testicular cancer	0.00408	0.00647	CcSEcCtD
Auranofin—Interstitial lung disease—Methotrexate—testicular cancer	0.00406	0.00645	CcSEcCtD
Auranofin—Weight decreased—Bleomycin—testicular cancer	0.00404	0.00641	CcSEcCtD
Auranofin—Pancytopenia—Dactinomycin—testicular cancer	0.00395	0.00627	CcSEcCtD
Auranofin—Neutropenia—Dactinomycin—testicular cancer	0.00389	0.00618	CcSEcCtD
Auranofin—Stomatitis—Bleomycin—testicular cancer	0.00388	0.00616	CcSEcCtD
Auranofin—Gastrointestinal haemorrhage—Cisplatin—testicular cancer	0.0038	0.00604	CcSEcCtD
Auranofin—Haematuria—Bleomycin—testicular cancer	0.00379	0.00602	CcSEcCtD
Auranofin—Alopecia—Vinblastine—testicular cancer	0.00374	0.00593	CcSEcCtD
Auranofin—Anaemia—Chlorambucil—testicular cancer	0.00371	0.00589	CcSEcCtD
Auranofin—IKBKB—Downstream TCR signaling—BCL10—testicular cancer	0.00371	0.0606	CbGpPWpGaD
Auranofin—Angioedema—Chlorambucil—testicular cancer	0.00367	0.00583	CcSEcCtD
Auranofin—Gingivitis—Methotrexate—testicular cancer	0.00366	0.00581	CcSEcCtD
Auranofin—Pancytopenia—Ifosfamide—testicular cancer	0.00362	0.00575	CcSEcCtD
Auranofin—Stomatitis—Dactinomycin—testicular cancer	0.00362	0.00574	CcSEcCtD
Auranofin—Leukopenia—Chlorambucil—testicular cancer	0.0036	0.00571	CcSEcCtD
Auranofin—Agranulocytosis—Dactinomycin—testicular cancer	0.00346	0.0055	CcSEcCtD
Auranofin—Gingivitis—Epirubicin—testicular cancer	0.00343	0.00544	CcSEcCtD
Auranofin—Anaemia—Vinblastine—testicular cancer	0.0034	0.0054	CcSEcCtD
Auranofin—Neuropathy peripheral—Ifosfamide—testicular cancer	0.00333	0.00529	CcSEcCtD
Auranofin—Stomatitis—Ifosfamide—testicular cancer	0.00332	0.00526	CcSEcCtD
Auranofin—Conjunctivitis—Ifosfamide—testicular cancer	0.00331	0.00525	CcSEcCtD
Auranofin—Leukopenia—Vinblastine—testicular cancer	0.0033	0.00523	CcSEcCtD
Auranofin—Proteinuria—Methotrexate—testicular cancer	0.00327	0.00519	CcSEcCtD
Auranofin—Haematuria—Ifosfamide—testicular cancer	0.00324	0.00515	CcSEcCtD
Auranofin—Protein urine present—Methotrexate—testicular cancer	0.00323	0.00512	CcSEcCtD
Auranofin—Thrombocytopenia—Chlorambucil—testicular cancer	0.00321	0.00509	CcSEcCtD
Auranofin—Agranulocytosis—Ifosfamide—testicular cancer	0.00317	0.00504	CcSEcCtD
Auranofin—Gingivitis—Doxorubicin—testicular cancer	0.00317	0.00504	CcSEcCtD
Auranofin—Alopecia—Bleomycin—testicular cancer	0.00316	0.00501	CcSEcCtD
Auranofin—Anorexia—Chlorambucil—testicular cancer	0.00313	0.00496	CcSEcCtD
Auranofin—Pancytopenia—Cisplatin—testicular cancer	0.00312	0.00496	CcSEcCtD
Auranofin—Glossitis—Methotrexate—testicular cancer	0.00312	0.00495	CcSEcCtD
Auranofin—Hepatic enzyme increased—Methotrexate—testicular cancer	0.00304	0.00483	CcSEcCtD
Auranofin—IKBKB—TCR signaling in naïve CD8+ T cells—BCL10—testicular cancer	0.00302	0.0493	CbGpPWpGaD
Auranofin—Dysphagia—Etoposide—testicular cancer	0.00301	0.00478	CcSEcCtD
Auranofin—Alopecia—Dactinomycin—testicular cancer	0.00294	0.00467	CcSEcCtD
Auranofin—Thrombocytopenia—Vinblastine—testicular cancer	0.00294	0.00467	CcSEcCtD
Auranofin—Visual impairment—Ifosfamide—testicular cancer	0.00294	0.00467	CcSEcCtD
Auranofin—Glossitis—Epirubicin—testicular cancer	0.00292	0.00463	CcSEcCtD
Auranofin—Dyspepsia—Chlorambucil—testicular cancer	0.00289	0.00458	CcSEcCtD
Auranofin—Anaemia—Bleomycin—testicular cancer	0.00287	0.00456	CcSEcCtD
Auranofin—Neuropathy peripheral—Cisplatin—testicular cancer	0.00287	0.00456	CcSEcCtD
Auranofin—Anorexia—Vinblastine—testicular cancer	0.00286	0.00455	CcSEcCtD
Auranofin—Pancytopenia—Etoposide—testicular cancer	0.00286	0.00454	CcSEcCtD
Auranofin—Stomatitis—Cisplatin—testicular cancer	0.00286	0.00454	CcSEcCtD
Auranofin—Eye disorder—Ifosfamide—testicular cancer	0.00285	0.00453	CcSEcCtD
Auranofin—Decreased appetite—Chlorambucil—testicular cancer	0.00285	0.00452	CcSEcCtD
Auranofin—Conjunctivitis—Cisplatin—testicular cancer	0.00285	0.00452	CcSEcCtD
Auranofin—Neutropenia—Etoposide—testicular cancer	0.00282	0.00447	CcSEcCtD
Auranofin—Melaena—Methotrexate—testicular cancer	0.00281	0.00446	CcSEcCtD
Auranofin—Leukopenia—Bleomycin—testicular cancer	0.00278	0.00442	CcSEcCtD
Auranofin—IKBKB—TCR signaling—BCL10—testicular cancer	0.00277	0.0453	CbGpPWpGaD
Auranofin—Glossitis—Doxorubicin—testicular cancer	0.0027	0.00429	CcSEcCtD
Auranofin—Aplastic anaemia—Methotrexate—testicular cancer	0.0027	0.00429	CcSEcCtD
Auranofin—Alopecia—Ifosfamide—testicular cancer	0.0027	0.00428	CcSEcCtD
Auranofin—Gastrointestinal pain—Chlorambucil—testicular cancer	0.00268	0.00426	CcSEcCtD
Auranofin—Anaemia—Dactinomycin—testicular cancer	0.00268	0.00425	CcSEcCtD
Auranofin—Neuropathy peripheral—Etoposide—testicular cancer	0.00263	0.00418	CcSEcCtD
Auranofin—Melaena—Epirubicin—testicular cancer	0.00263	0.00417	CcSEcCtD
Auranofin—Jaundice—Etoposide—testicular cancer	0.00262	0.00415	CcSEcCtD
Auranofin—Stomatitis—Etoposide—testicular cancer	0.00262	0.00415	CcSEcCtD
Auranofin—Decreased appetite—Vinblastine—testicular cancer	0.00261	0.00415	CcSEcCtD
Auranofin—Urticaria—Chlorambucil—testicular cancer	0.00261	0.00413	CcSEcCtD
Auranofin—Leukopenia—Dactinomycin—testicular cancer	0.0026	0.00412	CcSEcCtD
Auranofin—Abdominal pain—Chlorambucil—testicular cancer	0.00259	0.00411	CcSEcCtD
Auranofin—Constipation—Vinblastine—testicular cancer	0.00257	0.00408	CcSEcCtD
Auranofin—IKBKB—Activation of NF-kappaB in B cells—BCL10—testicular cancer	0.00257	0.0419	CbGpPWpGaD
Auranofin—Visual impairment—Cisplatin—testicular cancer	0.00254	0.00402	CcSEcCtD
Auranofin—IKBKB—TCR signaling in naïve CD4+ T cells—BCL10—testicular cancer	0.00254	0.0414	CbGpPWpGaD
Auranofin—Aplastic anaemia—Epirubicin—testicular cancer	0.00253	0.00401	CcSEcCtD
Auranofin—Agranulocytosis—Etoposide—testicular cancer	0.00251	0.00398	CcSEcCtD
Auranofin—IKBKB—BCR signaling pathway—BCL10—testicular cancer	0.00251	0.0409	CbGpPWpGaD
Auranofin—Thrombocytopenia—Bleomycin—testicular cancer	0.00249	0.00394	CcSEcCtD
Auranofin—Eye disorder—Cisplatin—testicular cancer	0.00246	0.0039	CcSEcCtD
Auranofin—Gastrointestinal pain—Vinblastine—testicular cancer	0.00246	0.0039	CcSEcCtD
Auranofin—Anaemia—Ifosfamide—testicular cancer	0.00246	0.0039	CcSEcCtD
Auranofin—Melaena—Doxorubicin—testicular cancer	0.00243	0.00386	CcSEcCtD
Auranofin—Angioedema—Ifosfamide—testicular cancer	0.00243	0.00385	CcSEcCtD
Auranofin—Anorexia—Bleomycin—testicular cancer	0.00242	0.00384	CcSEcCtD
Auranofin—Leukopenia—Ifosfamide—testicular cancer	0.00238	0.00378	CcSEcCtD
Auranofin—Abdominal pain—Vinblastine—testicular cancer	0.00238	0.00377	CcSEcCtD
Auranofin—Aplastic anaemia—Doxorubicin—testicular cancer	0.00234	0.00371	CcSEcCtD
Auranofin—Alopecia—Cisplatin—testicular cancer	0.00233	0.00369	CcSEcCtD
Auranofin—Pruritus—Chlorambucil—testicular cancer	0.00232	0.00368	CcSEcCtD
Auranofin—Thrombocytopenia—Dactinomycin—testicular cancer	0.00232	0.00368	CcSEcCtD
Auranofin—Flatulence—Cisplatin—testicular cancer	0.00226	0.00358	CcSEcCtD
Auranofin—Anorexia—Dactinomycin—testicular cancer	0.00226	0.00358	CcSEcCtD
Auranofin—Eye disorder—Etoposide—testicular cancer	0.00225	0.00358	CcSEcCtD
Auranofin—Diarrhoea—Chlorambucil—testicular cancer	0.00224	0.00356	CcSEcCtD
Auranofin—Dermatitis exfoliative—Methotrexate—testicular cancer	0.00221	0.00351	CcSEcCtD
Auranofin—Decreased appetite—Bleomycin—testicular cancer	0.00221	0.0035	CcSEcCtD
Auranofin—Alopecia—Etoposide—testicular cancer	0.00213	0.00338	CcSEcCtD
Auranofin—Thrombocytopenia—Ifosfamide—testicular cancer	0.00212	0.00337	CcSEcCtD
Auranofin—Anaemia—Cisplatin—testicular cancer	0.00212	0.00336	CcSEcCtD
Auranofin—Vomiting—Chlorambucil—testicular cancer	0.00209	0.00331	CcSEcCtD
Auranofin—Dermatitis exfoliative—Epirubicin—testicular cancer	0.00207	0.00329	CcSEcCtD
Auranofin—Anorexia—Ifosfamide—testicular cancer	0.00207	0.00328	CcSEcCtD
Auranofin—Decreased appetite—Dactinomycin—testicular cancer	0.00206	0.00327	CcSEcCtD
Auranofin—Diarrhoea—Vinblastine—testicular cancer	0.00206	0.00326	CcSEcCtD
Auranofin—Dysgeusia—Etoposide—testicular cancer	0.00206	0.00326	CcSEcCtD
Auranofin—Leukopenia—Cisplatin—testicular cancer	0.00205	0.00325	CcSEcCtD
Auranofin—Urticaria—Bleomycin—testicular cancer	0.00202	0.0032	CcSEcCtD
Auranofin—IKBKB—TCR Signaling Pathway—BCL10—testicular cancer	0.00198	0.0323	CbGpPWpGaD
Auranofin—Gastrointestinal haemorrhage—Epirubicin—testicular cancer	0.00195	0.0031	CcSEcCtD
Auranofin—Nausea—Chlorambucil—testicular cancer	0.00195	0.00309	CcSEcCtD
Auranofin—Anaemia—Etoposide—testicular cancer	0.00194	0.00308	CcSEcCtD
Auranofin—Gastrointestinal pain—Dactinomycin—testicular cancer	0.00194	0.00307	CcSEcCtD
Auranofin—Dermatitis exfoliative—Doxorubicin—testicular cancer	0.00192	0.00304	CcSEcCtD
Auranofin—Vomiting—Vinblastine—testicular cancer	0.00191	0.00303	CcSEcCtD
Auranofin—Decreased appetite—Ifosfamide—testicular cancer	0.00189	0.00299	CcSEcCtD
Auranofin—Leukopenia—Etoposide—testicular cancer	0.00188	0.00298	CcSEcCtD
Auranofin—Abdominal pain—Dactinomycin—testicular cancer	0.00187	0.00297	CcSEcCtD
Auranofin—IKBKB—B Cell Receptor Signaling Pathway—BCL10—testicular cancer	0.00186	0.0304	CbGpPWpGaD
Auranofin—Constipation—Ifosfamide—testicular cancer	0.00185	0.00294	CcSEcCtD
Auranofin—Thrombocytopenia—Cisplatin—testicular cancer	0.00183	0.00291	CcSEcCtD
Auranofin—Gastrointestinal haemorrhage—Doxorubicin—testicular cancer	0.00181	0.00287	CcSEcCtD
Auranofin—Pruritus—Bleomycin—testicular cancer	0.0018	0.00285	CcSEcCtD
Auranofin—Eosinophilia—Methotrexate—testicular cancer	0.00179	0.00284	CcSEcCtD
Auranofin—Nausea—Vinblastine—testicular cancer	0.00178	0.00283	CcSEcCtD
Auranofin—Anorexia—Cisplatin—testicular cancer	0.00178	0.00283	CcSEcCtD
Auranofin—Gastrointestinal pain—Ifosfamide—testicular cancer	0.00177	0.00281	CcSEcCtD
Auranofin—Urticaria—Ifosfamide—testicular cancer	0.00172	0.00273	CcSEcCtD
Auranofin—Abdominal pain—Ifosfamide—testicular cancer	0.00171	0.00272	CcSEcCtD
Auranofin—Pancytopenia—Methotrexate—testicular cancer	0.00171	0.00272	CcSEcCtD
Auranofin—Dysphagia—Epirubicin—testicular cancer	0.00169	0.00268	CcSEcCtD
Auranofin—Neutropenia—Methotrexate—testicular cancer	0.00169	0.00268	CcSEcCtD
Auranofin—Thrombocytopenia—Etoposide—testicular cancer	0.00168	0.00266	CcSEcCtD
Auranofin—Eosinophilia—Epirubicin—testicular cancer	0.00167	0.00265	CcSEcCtD
Auranofin—Anorexia—Etoposide—testicular cancer	0.00163	0.00259	CcSEcCtD
Auranofin—Decreased appetite—Cisplatin—testicular cancer	0.00163	0.00258	CcSEcCtD
Auranofin—Diarrhoea—Dactinomycin—testicular cancer	0.00162	0.00257	CcSEcCtD
Auranofin—Vomiting—Bleomycin—testicular cancer	0.00161	0.00256	CcSEcCtD
Auranofin—Pancytopenia—Epirubicin—testicular cancer	0.0016	0.00254	CcSEcCtD
Auranofin—Rash—Bleomycin—testicular cancer	0.0016	0.00254	CcSEcCtD
Auranofin—Dermatitis—Bleomycin—testicular cancer	0.0016	0.00254	CcSEcCtD
Auranofin—Neutropenia—Epirubicin—testicular cancer	0.00158	0.00251	CcSEcCtD
Auranofin—Stomatitis—Methotrexate—testicular cancer	0.00157	0.00249	CcSEcCtD
Auranofin—Conjunctivitis—Methotrexate—testicular cancer	0.00156	0.00248	CcSEcCtD
Auranofin—Dysphagia—Doxorubicin—testicular cancer	0.00156	0.00248	CcSEcCtD
Auranofin—Eosinophilia—Doxorubicin—testicular cancer	0.00155	0.00245	CcSEcCtD
Auranofin—Pruritus—Ifosfamide—testicular cancer	0.00153	0.00244	CcSEcCtD
Auranofin—Haematuria—Methotrexate—testicular cancer	0.00153	0.00243	CcSEcCtD
Auranofin—Weight decreased—Epirubicin—testicular cancer	0.00153	0.00242	CcSEcCtD
Auranofin—Nausea—Bleomycin—testicular cancer	0.00151	0.00239	CcSEcCtD
Auranofin—Vomiting—Dactinomycin—testicular cancer	0.00151	0.00239	CcSEcCtD
Auranofin—Agranulocytosis—Methotrexate—testicular cancer	0.0015	0.00238	CcSEcCtD
Auranofin—Rash—Dactinomycin—testicular cancer	0.00149	0.00237	CcSEcCtD
Auranofin—Decreased appetite—Etoposide—testicular cancer	0.00149	0.00236	CcSEcCtD
Auranofin—Diarrhoea—Ifosfamide—testicular cancer	0.00148	0.00236	CcSEcCtD
Auranofin—Pancytopenia—Doxorubicin—testicular cancer	0.00148	0.00235	CcSEcCtD
Auranofin—Neuropathy peripheral—Epirubicin—testicular cancer	0.00148	0.00234	CcSEcCtD
Auranofin—Stomatitis—Epirubicin—testicular cancer	0.00147	0.00233	CcSEcCtD
Auranofin—Jaundice—Epirubicin—testicular cancer	0.00147	0.00233	CcSEcCtD
Auranofin—Constipation—Etoposide—testicular cancer	0.00147	0.00232	CcSEcCtD
Auranofin—Conjunctivitis—Epirubicin—testicular cancer	0.00146	0.00232	CcSEcCtD
Auranofin—Neutropenia—Doxorubicin—testicular cancer	0.00146	0.00232	CcSEcCtD
Auranofin—Haematuria—Epirubicin—testicular cancer	0.00144	0.00228	CcSEcCtD
Auranofin—Weight decreased—Doxorubicin—testicular cancer	0.00141	0.00224	CcSEcCtD
Auranofin—Nausea—Dactinomycin—testicular cancer	0.00141	0.00223	CcSEcCtD
Auranofin—Agranulocytosis—Epirubicin—testicular cancer	0.00141	0.00223	CcSEcCtD
Auranofin—Gastrointestinal pain—Etoposide—testicular cancer	0.0014	0.00222	CcSEcCtD
Auranofin—Visual impairment—Methotrexate—testicular cancer	0.00139	0.00221	CcSEcCtD
Auranofin—Vomiting—Ifosfamide—testicular cancer	0.00138	0.00219	CcSEcCtD
Auranofin—Rash—Ifosfamide—testicular cancer	0.00137	0.00217	CcSEcCtD
Auranofin—Dermatitis—Ifosfamide—testicular cancer	0.00137	0.00217	CcSEcCtD
Auranofin—Neuropathy peripheral—Doxorubicin—testicular cancer	0.00137	0.00217	CcSEcCtD
Auranofin—Urticaria—Etoposide—testicular cancer	0.00136	0.00216	CcSEcCtD
Auranofin—Jaundice—Doxorubicin—testicular cancer	0.00136	0.00215	CcSEcCtD
Auranofin—Stomatitis—Doxorubicin—testicular cancer	0.00136	0.00215	CcSEcCtD
Auranofin—Abdominal pain—Etoposide—testicular cancer	0.00135	0.00215	CcSEcCtD
Auranofin—Conjunctivitis—Doxorubicin—testicular cancer	0.00135	0.00215	CcSEcCtD
Auranofin—Eye disorder—Methotrexate—testicular cancer	0.00135	0.00214	CcSEcCtD
Auranofin—Haematuria—Doxorubicin—testicular cancer	0.00133	0.00211	CcSEcCtD
Auranofin—Visual impairment—Epirubicin—testicular cancer	0.0013	0.00207	CcSEcCtD
Auranofin—Agranulocytosis—Doxorubicin—testicular cancer	0.0013	0.00206	CcSEcCtD
Auranofin—Nausea—Ifosfamide—testicular cancer	0.00129	0.00204	CcSEcCtD
Auranofin—Diarrhoea—Cisplatin—testicular cancer	0.00128	0.00203	CcSEcCtD
Auranofin—Alopecia—Methotrexate—testicular cancer	0.00128	0.00203	CcSEcCtD
Auranofin—Eye disorder—Epirubicin—testicular cancer	0.00126	0.002	CcSEcCtD
Auranofin—Dysgeusia—Methotrexate—testicular cancer	0.00123	0.00195	CcSEcCtD
Auranofin—Pruritus—Etoposide—testicular cancer	0.00121	0.00192	CcSEcCtD
Auranofin—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—BCL10—testicular cancer	0.00121	0.0197	CbGpPWpGaD
Auranofin—Visual impairment—Doxorubicin—testicular cancer	0.00121	0.00191	CcSEcCtD
Auranofin—Alopecia—Epirubicin—testicular cancer	0.00119	0.0019	CcSEcCtD
Auranofin—Vomiting—Cisplatin—testicular cancer	0.00119	0.00189	CcSEcCtD
Auranofin—Rash—Cisplatin—testicular cancer	0.00118	0.00187	CcSEcCtD
Auranofin—Dermatitis—Cisplatin—testicular cancer	0.00118	0.00187	CcSEcCtD
Auranofin—Diarrhoea—Etoposide—testicular cancer	0.00117	0.00186	CcSEcCtD
Auranofin—Eye disorder—Doxorubicin—testicular cancer	0.00117	0.00185	CcSEcCtD
Auranofin—Anaemia—Methotrexate—testicular cancer	0.00116	0.00184	CcSEcCtD
Auranofin—Flatulence—Epirubicin—testicular cancer	0.00116	0.00184	CcSEcCtD
Auranofin—Dysgeusia—Epirubicin—testicular cancer	0.00115	0.00183	CcSEcCtD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—BCL10—testicular cancer	0.00115	0.0188	CbGpPWpGaD
Auranofin—Leukopenia—Methotrexate—testicular cancer	0.00113	0.00179	CcSEcCtD
Auranofin—Nausea—Cisplatin—testicular cancer	0.00111	0.00176	CcSEcCtD
Auranofin—ALB—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.00111	0.0181	CbGpPWpGaD
Auranofin—Alopecia—Doxorubicin—testicular cancer	0.00111	0.00175	CcSEcCtD
Auranofin—Vomiting—Etoposide—testicular cancer	0.00109	0.00173	CcSEcCtD
Auranofin—Anaemia—Epirubicin—testicular cancer	0.00109	0.00173	CcSEcCtD
Auranofin—Rash—Etoposide—testicular cancer	0.00108	0.00171	CcSEcCtD
Auranofin—Dermatitis—Etoposide—testicular cancer	0.00108	0.00171	CcSEcCtD
Auranofin—Flatulence—Doxorubicin—testicular cancer	0.00107	0.0017	CcSEcCtD
Auranofin—Dysgeusia—Doxorubicin—testicular cancer	0.00107	0.00169	CcSEcCtD
Auranofin—IKBKB—B Cell Activation—BCL10—testicular cancer	0.00107	0.0174	CbGpPWpGaD
Auranofin—Leukopenia—Epirubicin—testicular cancer	0.00105	0.00167	CcSEcCtD
Auranofin—Nausea—Etoposide—testicular cancer	0.00102	0.00161	CcSEcCtD
Auranofin—Anaemia—Doxorubicin—testicular cancer	0.00101	0.0016	CcSEcCtD
Auranofin—Thrombocytopenia—Methotrexate—testicular cancer	0.001	0.00159	CcSEcCtD
Auranofin—Anorexia—Methotrexate—testicular cancer	0.000978	0.00155	CcSEcCtD
Auranofin—Leukopenia—Doxorubicin—testicular cancer	0.000975	0.00155	CcSEcCtD
Auranofin—Thrombocytopenia—Epirubicin—testicular cancer	0.00094	0.00149	CcSEcCtD
Auranofin—IKBKB—AGE/RAGE pathway—MMP2—testicular cancer	0.000925	0.0151	CbGpPWpGaD
Auranofin—Anorexia—Epirubicin—testicular cancer	0.000915	0.00145	CcSEcCtD
Auranofin—Dyspepsia—Methotrexate—testicular cancer	0.000903	0.00143	CcSEcCtD
Auranofin—Decreased appetite—Methotrexate—testicular cancer	0.000892	0.00142	CcSEcCtD
Auranofin—Thrombocytopenia—Doxorubicin—testicular cancer	0.00087	0.00138	CcSEcCtD
Auranofin—Anorexia—Doxorubicin—testicular cancer	0.000847	0.00134	CcSEcCtD
Auranofin—Dyspepsia—Epirubicin—testicular cancer	0.000845	0.00134	CcSEcCtD
Auranofin—Gastrointestinal pain—Methotrexate—testicular cancer	0.000839	0.00133	CcSEcCtD
Auranofin—Decreased appetite—Epirubicin—testicular cancer	0.000835	0.00132	CcSEcCtD
Auranofin—Constipation—Epirubicin—testicular cancer	0.000821	0.0013	CcSEcCtD
Auranofin—Urticaria—Methotrexate—testicular cancer	0.000815	0.00129	CcSEcCtD
Auranofin—Abdominal pain—Methotrexate—testicular cancer	0.000811	0.00129	CcSEcCtD
Auranofin—Gastrointestinal pain—Epirubicin—testicular cancer	0.000785	0.00125	CcSEcCtD
Auranofin—Dyspepsia—Doxorubicin—testicular cancer	0.000782	0.00124	CcSEcCtD
Auranofin—Decreased appetite—Doxorubicin—testicular cancer	0.000772	0.00123	CcSEcCtD
Auranofin—Urticaria—Epirubicin—testicular cancer	0.000763	0.00121	CcSEcCtD
Auranofin—Constipation—Doxorubicin—testicular cancer	0.00076	0.00121	CcSEcCtD
Auranofin—Abdominal pain—Epirubicin—testicular cancer	0.000759	0.0012	CcSEcCtD
Auranofin—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—KITLG—testicular cancer	0.000728	0.0119	CbGpPWpGaD
Auranofin—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000727	0.00115	CcSEcCtD
Auranofin—Pruritus—Methotrexate—testicular cancer	0.000726	0.00115	CcSEcCtD
Auranofin—Urticaria—Doxorubicin—testicular cancer	0.000706	0.00112	CcSEcCtD
Auranofin—Abdominal pain—Doxorubicin—testicular cancer	0.000702	0.00111	CcSEcCtD
Auranofin—Diarrhoea—Methotrexate—testicular cancer	0.000702	0.00111	CcSEcCtD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—KITLG—testicular cancer	0.000695	0.0113	CbGpPWpGaD
Auranofin—Pruritus—Epirubicin—testicular cancer	0.000679	0.00108	CcSEcCtD
Auranofin—Diarrhoea—Epirubicin—testicular cancer	0.000657	0.00104	CcSEcCtD
Auranofin—Vomiting—Methotrexate—testicular cancer	0.000652	0.00104	CcSEcCtD
Auranofin—Rash—Methotrexate—testicular cancer	0.000647	0.00103	CcSEcCtD
Auranofin—Dermatitis—Methotrexate—testicular cancer	0.000646	0.00103	CcSEcCtD
Auranofin—IKBKB—B Cell Activation—KITLG—testicular cancer	0.000643	0.0105	CbGpPWpGaD
Auranofin—Pruritus—Doxorubicin—testicular cancer	0.000629	0.000998	CcSEcCtD
Auranofin—Vomiting—Epirubicin—testicular cancer	0.000611	0.000969	CcSEcCtD
Auranofin—Nausea—Methotrexate—testicular cancer	0.00061	0.000967	CcSEcCtD
Auranofin—Diarrhoea—Doxorubicin—testicular cancer	0.000608	0.000965	CcSEcCtD
Auranofin—Rash—Epirubicin—testicular cancer	0.000605	0.000961	CcSEcCtD
Auranofin—Dermatitis—Epirubicin—testicular cancer	0.000605	0.00096	CcSEcCtD
Auranofin—Nausea—Epirubicin—testicular cancer	0.00057	0.000905	CcSEcCtD
Auranofin—Vomiting—Doxorubicin—testicular cancer	0.000565	0.000896	CcSEcCtD
Auranofin—ALB—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000562	0.00918	CbGpPWpGaD
Auranofin—Rash—Doxorubicin—testicular cancer	0.00056	0.000889	CcSEcCtD
Auranofin—Dermatitis—Doxorubicin—testicular cancer	0.00056	0.000888	CcSEcCtD
Auranofin—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—FGFR3—testicular cancer	0.000541	0.00883	CbGpPWpGaD
Auranofin—Nausea—Doxorubicin—testicular cancer	0.000528	0.000837	CcSEcCtD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—FGFR3—testicular cancer	0.000516	0.00843	CbGpPWpGaD
Auranofin—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—KIT—testicular cancer	0.000497	0.00811	CbGpPWpGaD
Auranofin—IKBKB—B Cell Activation—FGFR3—testicular cancer	0.000478	0.0078	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—KIT—testicular cancer	0.000474	0.00774	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—KITLG—testicular cancer	0.000473	0.00772	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—BCL10—testicular cancer	0.000448	0.00731	CbGpPWpGaD
Auranofin—IKBKB—B Cell Activation—KIT—testicular cancer	0.000439	0.00716	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—BCL10—testicular cancer	0.00043	0.00702	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—FGFR3—testicular cancer	0.000352	0.00574	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—INSL3—testicular cancer	0.000345	0.00563	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—KIT—testicular cancer	0.000323	0.00527	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—KITLG—testicular cancer	0.00027	0.00441	CbGpPWpGaD
Auranofin—IKBKB—Immune System—BCL10—testicular cancer	0.000261	0.00426	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—KITLG—testicular cancer	0.000259	0.00423	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	0.000215	0.0035	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—FGFR3—testicular cancer	0.000201	0.00327	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—FGFR3—testicular cancer	0.000193	0.00314	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—KIT—testicular cancer	0.000184	0.00301	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—KIT—testicular cancer	0.000177	0.00289	CbGpPWpGaD
Auranofin—IKBKB—Immune System—KITLG—testicular cancer	0.000157	0.00257	CbGpPWpGaD
Auranofin—IKBKB—Immune System—FGFR3—testicular cancer	0.000117	0.00191	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—H2AFZ—testicular cancer	0.00011	0.0018	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—STK11—testicular cancer	0.00011	0.00179	CbGpPWpGaD
Auranofin—IKBKB—Immune System—KIT—testicular cancer	0.000107	0.00175	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—KITLG—testicular cancer	0.000102	0.00166	CbGpPWpGaD
Auranofin—ALB—Metabolism—HPGDS—testicular cancer	9.56e-05	0.00156	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—FGFR3—testicular cancer	7.55e-05	0.00123	CbGpPWpGaD
Auranofin—ALB—Metabolism—STK11—testicular cancer	6.94e-05	0.00113	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—KIT—testicular cancer	6.94e-05	0.00113	CbGpPWpGaD
